VEGFA and hypertensive disorder: The final BCVA was positively correlated with the baseline BCVA (r = 0.682, p < 0.001), the history of hypertension (r = 0.288, p = 0.040), the presence of macular edema at baseline (r = 0.540, p < 0.001), CFT at baseline (r = 0.415, p = 0.002), PED height at baseline (r = 0.370, p = 0.007), the presence of macular edema after anti-VEGF injections (r = 0.350, p = 0.012), CFT after anti-VEGF injections (r = 0.364, p = 0.009), and PED height after anti-VEGF injections (r = 0.279, p = 0.048).